Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
暂无分享,去创建一个
Paul J Hertzog | Douglas J Hilton | D. Hilton | P. Hertzog | P. Crack | A. Mansell | Pearl Gray | L. O’Neill | S. Nicholson | Sarah L. Doyle | Luke A J O'Neill | Peter J Crack | Sandra E Nicholson | Ashley Mansell | Jennifer E Fenner | Pearl Gray | Sarah L Doyle | Rosealee Smith | Jennifer E. Fenner | Rosealee Smith
[1] J. Ihle,et al. Re-examination of the Role of Suppressor of Cytokine Signaling 1 (SOCS1) in the Regulation of Toll-like Receptor Signaling*♦ , 2004, Journal of Biological Chemistry.
[2] J. Tschopp,et al. MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.
[3] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[4] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[5] D J Rawlings,et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.
[6] R. Flavell,et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors , 2002, Nature.
[7] W. Alexander,et al. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.
[8] Daniel R. Caffrey,et al. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.
[9] A. Yoshimura,et al. Regulation of TLR signaling and inflammation by SOCS family proteins , 2004, Journal of leukocyte biology.
[10] K. Heeg,et al. Suppressor of Cytokine Signaling (SOCS) Proteins Indirectly Regulate Toll-like Receptor Signaling in Innate Immune Cells*♦ , 2004, Journal of Biological Chemistry.
[11] Kenji Nakanishi,et al. SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.
[12] T. Naka,et al. Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. , 1999, Trends in biochemical sciences.
[13] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[14] R. Ulevitch,et al. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors , 2004, Nature Immunology.
[15] W. V. Berghe,et al. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit , 2002 .
[16] A. Bowie,et al. The Toll-IL-1 receptor adaptor family grows to five members. , 2003, Trends in immunology.
[17] J. G. Zhang,et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] Paul J Hertzog,et al. SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.
[19] S. Akira,et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.
[20] 金城 市子. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation , 2003 .
[21] Dirk E. Smith,et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.
[22] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[23] Shuang Chen,et al. Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling* , 2005, Journal of Biological Chemistry.
[24] A. Dunne,et al. Adaptor usage and Toll‐like receptor signaling specificity , 2005, FEBS letters.
[25] M. Sweet,et al. A Novel Pathway Regulating Lipopolysaccharide-Induced Shock by ST2/T1 Via Inhibition of Toll-Like Receptor 4 Expression1 , 2001, The Journal of Immunology.
[26] C. Jefferies,et al. Bruton's Tyrosine Kinase Is Involved in p65-mediated Transactivation and Phosphorylation of p65 on Serine 536 during NFκB Activation by Lipopolysaccharide* , 2005, Journal of Biological Chemistry.
[27] Paul J Hertzog,et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity , 2006, Nature Immunology.
[28] T. Fujita,et al. TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* , 2003, Journal of Biological Chemistry.
[29] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[30] S. Minoguchi,et al. The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2* , 2001, The Journal of Biological Chemistry.
[31] W. Alexander,et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.
[32] W. Alexander,et al. The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.
[33] A. Yoshimura,et al. Negative regulation of cytokine signaling and inflammatory diseases. , 2003, Current opinion in pharmacology.
[34] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[35] A. Tarakhovsky,et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105 , 2005, Nature Immunology.
[36] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[37] S. Rogers,et al. PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.
[38] Douglas K. Miller,et al. The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.
[39] N. Reiner,et al. Dual Receptors and Distinct Pathways Mediate Interleukin-1 Receptor-associated Kinase Degradation in Response to Lipopolysaccharide , 2004, Journal of Biological Chemistry.
[40] P. Hertzog,et al. Mal Interacts with Tumor Necrosis Factor Receptor-associated Factor (TRAF)-6 to mediate NF-κB Activation by Toll-like Receptor (TLR)-2 and TLR4* , 2004, Journal of Biological Chemistry.
[41] Charles A. Janeway,et al. IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.
[42] G. Stark,et al. SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.